抗病毒口服液治疗小儿病毒性感冒的有效性分析与研究

Analysis and Study on the Efficacy of Antiviral Oral-Liquid in the Treatment of Children With Influenza

目的探究抗病毒口服液治疗小儿病毒性感冒的有效性。方法抽取80例2016年1月—2017年6月小儿病毒性感冒患儿按随机表分组。对照组采用常规的药物治疗;抗病毒口服液组则给予抗病毒口服液治疗。比较两组患儿病毒性感冒控制率;症状改善时间、发热消退时间、平均治愈时间;用药过程不良反应发生率。结果抗病毒口服液组患儿病毒性感冒控制率比对照组高,P<0.05;抗病毒口服液组症状改善时间、发热消退时间、平均治愈时间比对照组短,P<0.05;抗病毒口服液组用药过程不良反应发生率比对照组低,P<0.05。结论抗病毒口服液治疗小儿病毒性感冒的有效性高,且不良反应少,安全性高,可缩短疗程,更好改善患儿预后。

Objective To explore the effcacy of Antiviral Oral-Liquid in the treatment of children with infuenza. Methods 80 children with infuenza from January 2016 to June 2017 were grouped according to random tables. The control group was treated with conventional medication, while the antiviral oral-liquid group was given the treatment of antiviral oral-liquid. The control rate of the two groups of viral colds was compared, the time of symptom improvement, the time of fever subsiding, the average cure time, and the incidence of adverse reaction in the drug use. Results The control rate of infuenza virus in the antiviral oral-liquid group was higher than that of the control group, P 〈 0.05. The symptom improvement time, fever subsiding time and average cure time in antiviral oral-liquid group were shorter than those of the control group, P 〈 0.05; the incidence of adverse drug reactions in the antiviral oral-liquid group was lower than that of the control group, P 〈 0.05. Conclusion Antiviral oral-liquid has high effcacy in treating children with infuenza, with less adverse reactions and high safety. It can shorten the course of treatment and better improve the prognosis of children.